Research-Grade Peptide
PT-141
A melanocortin-receptor agonist studied for central signalling activity in preclinical models.
18 in stock
- ✓ ≥ 99% purity by HPLC
- ✓ Third-party tested in Canada, COA on every batch
- ✓ Discreet, tracked shipping · free over $250
A melanocortin-receptor agonist studied for central signalling activity in preclinical models.
Further reading: PT-141 on The Peptide Guide — an independent Canadian reference with compound profiles and a reconstitution calculator. Educational only; nothing there is a statement about this product.
Research background
PT-141, also known as bremelanotide, is a synthetic cyclic heptapeptide derived from Melanotan II. Unlike its parent compound it acts primarily through central melanocortin receptors rather than producing pigmentary effects. Research examines PT-141 through melanocortin-receptor signalling, principally MC3R and MC4R, in preclinical neuroendocrine models. The compound has been the subject of a separate pharmaceutical development programme; that programme is distinct from, and does not describe, material supplied for laboratory research. Research Use Only. Not for human or veterinary use.
Supplied as a lyophilised powder for laboratory research use only. Any context described above refers to published preclinical or in-vitro research — not to human or veterinary use.